Hubungan penggunaan antibiotik empiris terhadap outcome terapi pasien community acquired pneumonia (CAP) di RSUP Fatmawati Jakarta

  • Feri Setiadi Stikes Prima Indonesia
  • Magdalena Niken Oktovina RSUP Fatmawati
  • Umi Salamah Stikes Prima Indonesia
  • Tengku Nadiah Fadillah Sekolah Tinggi Teknologi Industri dan Farmasi Bogor

Abstract

Backgrounds: Community Acquired Pneumonia (CAP) is an inflammation of the lungs that is mostly caused by bacteria. Based on the 2018 Basic Health Research (RISKESDAS) data, the prevalence of pneumonia has increased every year, namely in 2013 (1.8%) and in 2018 (2.0%).
Objective: This study aims to describes the relationship between empirical antibiotic use and empirical antibiotic use on the therapeutic outcome of CAP patients.
Methods: This study was conducted retrospectively with a cross sectional method on CAP patients who met the inclusion criteria in the period January–December 2019.
Results: The results of the study were patients aged 17-65 years 48 patients (65.8%), for male gender 39 patients (53.4%). The use of a single antibiotic ceftriaxone (42.5%) and a combination antibiotic ceftriaxone+levofloxacin (35.6%). Cephalosporin group of antibiotics (50.7%) and a combination of cephalosporin+quinolone group (42.5%).
Conclusion: The longest duration of antibiotic use was in the range of 1-7 days (90.4%). The results of analysis of Chi-Square resulted having a Value of 0.75 (> 0.05), meaning that there was no relationship between the duration of empirical antibiotic use on the patient's therapeutic outcome (CAP). The duration of empirical antibiotic use has a value of 0.025 (<0.05), meaning that there is a relationship between the duration of the use of empirical antibiotics on the patient's therapeutic outcomes (CAP).

Author Biographies

Feri Setiadi, Stikes Prima Indonesia

Jl.Raya BabelanNo. 9,6 KM,RW.6, Kebalen,Babelan,  Bekasi,Jawa Barat

Magdalena Niken Oktovina, RSUP Fatmawati

Jl. RS Fatmawati Raya No 4, RT 1/RW 8, Cilandak Barat, Cilandak, Kota Jakarta Selatan

Umi Salamah, Stikes Prima Indonesia

Jl. Raya Babelan No.9,6 KM, RW.6, Kebalen, Babelan, Bekasi, Jawa Barat

Tengku Nadiah Fadillah, Sekolah Tinggi Teknologi Industri dan Farmasi Bogor

Jl. Kumbang No. 23 Bogor, Jawa Barat

References

Kementerian kesehatan RI. Departemen kesehatan republik indonesia jakarta 2008. Dep Kesehat republik Indones jakarta 2008. 2008;82.

Sari EF, Rumende CM, Harimurti K. Faktor–Faktor yang Berhubungan dengan Diagnosis Pneumonia pada Pasien Usia Lanjut. J Penyakit Dalam Indones. 2017;3(4):183.

Kemenkes RI. Hasil Riset Kesehatan Dasar Tahun 2018. Kementrian Kesehat RI. 2018;53(9):1689–99.

Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61–111.

Adani N, Arkhaesi N, Anam M. Hubungan Usia Anak Dan Diagnosis Dengan Rasionalitas Penggunaan Antibiotik Pada Pasien Anak : Di Puskesmas Rowosari Semarang. J Kedokt Diponegoro. 2015;4(4):1277–85.

SAFITRI S. Evaluasi Penggunaan Antibiotik Pada Pasien Pneumonia Di Instalasi Rawat Inap Rs “X” Klaten Tahun 2015. CoreAcUk. 2015;

Başyiğit S. Clinical pulmonary infection score (CPIS) as a screening tool in ventilatory associated pneumonia (VAP). SiSli Etfal Hastan Tip Bul / Med Bull Sisli Hosp. 2017;(2):133–41.

Perhimpunan Dokter Paru Indonesia. Pneumonia komuniti 1973 - 2003. Pneumonia Komuniti (Pedoman diagnosis dan penatalaksanaan). 2003;6.

Ilmi T, Yulia R, Herawati F, Farmasi PS, Kadiri U, Farmasi PS, et al. Umum Daerah Tulungagung Evaluation Of Antibiotic Use On Pneumonia Patients In Tulungagung Regional Indonesia ( PDPI, 2014 ), Infections Diseases Sociaty of America / American Thoracis Consensus Guidelines on the Managemen of Community-Acquired Pneumonia . 2020;1(2).

Rahayu YD, Wahyono D, Mustofa. Evaluasi Rasionalitas Penggunaan Antibiotik Terhadap Luaran Pada Pasien Anak Penderita Pneumonia. JournalUgmAcId. 2014;4(1):264–70.

RS. dr. R. Goeteng Taroenadibrata Purbalingga. Profil RSUD dr. R. Goeteng Taroenadibrata Purbalingga Tahun 2018. 2018;ii–75.

2018 KK. Kementrian Kesehatan Badan Ppsdm Kesehatan 2018. Badan Ppsdm Kesehat 2018. 2018;

Islam Z, Qodariyah SM, Nursehah ENE. Penggunaan Antibiotik Pada Terapi Community Acquired Pneumonia di RSUD Pasar Rebo dan RSUD Tarakan di Jakarta Tahun 2014. J Sains dan Teknol Farm. 2017;19(1):1–8.

Pangalila F, Soepandi P, Albandjar C, Sukesih L, Enty. Pedoman Antibiotik Empirik di Unit Rawat Intensif. 2019. 31 p.

Feri. Analisis Faktor-Faktor Yang Mempengaruhi Outcome Terapi Pasien Pneumonia Di Rumah Sakit Umum Pusat Fatmawati Jakarta. Αγαη. 2019;8(5):55.

Published
2022-06-15
How to Cite
1.
Setiadi F, Niken Oktovina M, Salamah U, Nadiah Fadillah T. Hubungan penggunaan antibiotik empiris terhadap outcome terapi pasien community acquired pneumonia (CAP) di RSUP Fatmawati Jakarta . Media ilmu kesehatan [Internet]. 2022Jun.15 [cited 2022Jul.5];10(3):261-9. Available from: https://ejournal.unjaya.ac.id/index.php/mik/article/view/643